Alessandro Schipani

1.2k citations

19 papers · 948 indexed · 1 hit paper · h-index 14

Molecular Biology
Infectious Diseases top 5%
Computational Theory and Mathematics top 2%
Organic Chemistry top 10%
Virology top 5%

Co-authors: Ian H. Gilbert Ruth Brenk Paul G. Wyatt Julie A. Frearson Andrew Owen Saye Khoo Marco Siccardi Geraint Davies
Topics: HIV/AIDS drug development and treatment (13 papers)Pharmacological Effects and Toxicity Studies (6 papers)Biochemical and Molecular Research (5 papers)
Cited by: Virology Infectious Diseases Computational Theory and Mathematics
Journals: Journal of Medicinal Chemistry Antimicrobial Agents and Chemotherapy Clinical Pharmacology & Therapeutics
Partner nations: United Kingdom Switzerland Spain

In The Last Decade

Alessandro Schipani

19 papers receiving 935 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases

2007 482 citations Ruth Brenk, Alessandro Schipani et al. ChemMedChem profile →

Peers

Countries citing papers authored by Alessandro Schipani

Since Specialization

Citations

This map shows the geographic impact of Alessandro Schipani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Schipani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Schipani more than expected).

Fields of papers citing papers by Alessandro Schipani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Schipani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Schipani. The network helps show where Alessandro Schipani may publish in the future.

Co-authorship network of co-authors of Alessandro Schipani

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Schipani. A scholar is included among the top collaborators of Alessandro Schipani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Schipani. Alessandro Schipani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Evaluation of universal versus genotype-guided efavirenz dose reduction in pregnant women using population pharmacokinetic modelling 2017 ·Journal of Antimicrobial Chemotherapy ·Adeniyi Olagunju,Alessandro Schipani,Oluseye O. Bolaji,Saye Khoo,Andrew Owen	8
2	Genetic Determinants of the Pharmacokinetic Variability of Rifampin in Malawian Adults with Pulmonary Tuberculosis 2017 ·Antimicrobial Agents and Chemotherapy ·Derek J. Sloan,(unknown),Alessandro Schipani,Deirdre Egan,Henry C. Mwandumba,Stephen A. Ward,David Waterhouse,(unknown),Theresa J. Allain,Andrew Owen,Saye Khoo,Geraint Davies	34
3	Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model 2016 ·Antimicrobial Agents and Chemotherapy ·Yanmin Hu,Henry Pertinez,Fátima Ortega-Muro,(unknown),Yingjun Liu,Alessandro Schipani,Geraint Davies,Anthony Coates	17
4	Observational infant exploratory [¹⁴C]‐paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis 2015 ·British Journal of Clinical Pharmacology ·Colin Garner,Kevin B. Park,Neil French,Caroline J. Earnshaw,Alessandro Schipani,Andrew Selby,(unknown),(unknown),Francis P. Crawley,Wouter H. J. Vaes,Esther van Duijn,(unknown),Heili Varendi,(unknown),Grzegorz Grynkiewicz,Wioleta Maruszak,M. Turner	19
5	A simultaneous population pharmacokinetic analysis of rifampicin in Malawian adults and children 2015 ·British Journal of Clinical Pharmacology ·Alessandro Schipani,Henry Pertinez,(unknown),Elizabeth Molyneux,N. López Segura,Fraction K. Dzinjalamala,Joep J. van Oosterhout,Stephen A. Ward,Saye Khoo,Geraint Davies	21
6	CYP3A422 (c.522-191 C>T; rs35599367) is associated with lopinavir pharmacokinetics in HIV-positive adults 2014 ·Pharmacogenetics and Genomics* ·Adeniyi Olagunju,Alessandro Schipani,Marco Siccardi,Deirdre Egan,Saye Khoo,David Back,Andrew Owen	20
7	Use of In Vitro to In Vivo Extrapolation to Predict the Optimal Strategy for Patients Switching from Efavirenz to Maraviroc or Nevirapine 2014 ·Clinical Pharmacokinetics ·Alessandro Schipani,David Back,Andrew Owen,Geraint Davies,Saye Khoo,Marco Siccardi	2
8	ABSTRACT 707 2014 ·Pediatric Critical Care Medicine ·Andrew Selby,(unknown),(unknown),(unknown),R.C. Garner,Caroline J. Earnshaw,Neil French,Alessandro Schipani,Grzegorz Grynkiewicz,Wioleta Maruszak,(unknown),(unknown),(unknown),Heili Varendi,Jana Lass,(unknown),(unknown),M. Turner	1
9	Investigation of acyclic uridine amide and 5′-amido nucleoside analogues as potential inhibitors of the Plasmodium falciparum dUTPase 2013 ·Bioorganic & Medicinal Chemistry ·(unknown),Alessandro Schipani,(unknown),Eliseo Recio,Marcel Kaiser,Pia Kahnberg,Dolores González‐Pacanowska,Nils Gunnar Johansson,Ian H. Gilbert	6
10	Antiretroviral Solid Drug Nanoparticles with Enhanced Oral Bioavailability: Production, Characterization, and In Vitro–In Vivo Correlation 2013 ·Advanced Healthcare Materials ·Tom O. McDonald,Marco Giardiello,Philip Martin,Marco Siccardi,Neill J. Liptrott,Darren Smith,(unknown),Paul Curley,Alessandro Schipani,Saye Khoo,James P. Long,Alison J. Foster,Steve P. Rannard,Andrew Owen	70
11	Simultaneous Population Pharmacokinetic Modelling of Atazanavir and Ritonavir in HIV-Infected Adults and Assessment of Different Dose Reduction Strategies 2012 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Alessandro Schipani,Laura Dickinson,Marta Boffito,Rupert P. Austin,Andrew Owen,David Back,Saye Khoo,Geraint Davies	10
12	Pharmacokinetic and Pharmacodynamic Analysis of Efavirenz Dose Reduction Using an In Vitro–In Vivo Extrapolation Model 2012 ·Clinical Pharmacology & Therapeutics ·Marco Siccardi,Lisa M. Almond,Alessandro Schipani,Chantal Csajka,Catia Marzolini,Christoph Wyen,Norbert H. Brockmeyer,Marta Boffito,Andrew Owen,David Back	39
13	Estimation of the Effect of Slco1B1 Polymorphisms on Lopinavir Plasma Concentration in HIV-Infected Adults 2012 ·Antiviral Therapy ·Alessandro Schipani,Deirdre Egan,Laura Dickinson,Geraint Davies,Marta Boffito,Mike Youle,Saye Khoo,David Back,Andrew Owen	21
14	Design, Synthesis, and Evaluation of 5′‐Diphenyl Nucleoside Analogues as Inhibitors of the Plasmodium falciparum dUTPase 2011 ·ChemMedChem ·(unknown),Beatriz Baragaña,Alessandro Schipani,(unknown),(unknown),Eliseo Recio,Marcel Kaiser,Jean L. Whittingham,S.M. Roberts,M.B. Shevtsov,J.A. Brannigan,Pia Kahnberg,Reto Brun,Keith S. Wilson,Dolores González‐Pacanowska,Nils Gunnar Johansson,Ian H. Gilbert	28
15	Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals 2011 ·Journal of Antimicrobial Chemotherapy ·Alessandro Schipani,Christoph Wyen,Tabitha Mahungu,Heidy Hendra,David Egan,Marco Siccardi,Geraint Davies,SH Khoo,Gerd Fätkenheuer,M Youle,Jürgen K. Rockstroh,Norbert H. Brockmeyer,M. A. Johnson,Andrew Owen,David Back,(unknown)	40
16	Population Pharmacokinetic Modeling of the Association between 63396C→T Pregnane X Receptor Polymorphism and Unboosted Atazanavir Clearance 2010 ·Antimicrobial Agents and Chemotherapy ·Alessandro Schipani,Marco Siccardi,Antonio D’Avolio,Lorena Baietto,Marco Simiele,Stefano Bonora,Sonia Rodríguez‐Nóvoa,Lorena Cuenca‐Bermejo,Vincent Soriano,Nitipatana Chierakul,(unknown),(unknown),Janelle M. Hoskins,(unknown),Howard L. McLeod,Geraint Davies,Saye Khoo,David Back,Giovanni Di Perri,Andrew Owen	60
17	Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseasesbreakdown → 2007 ·ChemMedChem ·Ruth Brenk,Alessandro Schipani,(unknown),(unknown),Ian H. Gilbert,Julie A. Frearson,Paul G. Wyatt	482
18	Acyclic Nucleoside Analogues as Inhibitors ofPlasmodiumfalciparumdUTPase 2006 ·Journal of Medicinal Chemistry ·(unknown),G.F. Ruda,Alessandro Schipani,(unknown),Isabel Leal,(unknown),Marcel Kaiser,Reto Brun,Luis M. Ruiz‐Pérez,(unknown),Nils Gunnar Johansson,Dolores González‐Pacanowska,Ian H. Gilbert	53
19	Design, synthesis and evaluation of novel uracil amino acid conjugates for the inhibition of Trypanosoma cruzi dUTPase 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Alessandro Schipani,(unknown),Luis M. Ruiz‐Pérez,Marcel Kaiser,Reto Brun,Dolores González‐Pacanowska,Ian H. Gilbert	17

About Alessandro Schipani

Alessandro Schipani is a scholar working on Infectious Diseases, Virology and Pediatrics, Perinatology and Child Health, having authored 19 papers that have together received 948 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (13 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Biochemical and Molecular Research (5 papers). The work is most often cited by research in Virology (126 citations), Infectious Diseases (306 citations) and Computational Theory and Mathematics (244 citations). Alessandro Schipani has collaborated with scholars based in United Kingdom, Switzerland and Spain. Frequent co-authors include Ian H. Gilbert, Ruth Brenk, Paul G. Wyatt, Julie A. Frearson, Andrew Owen, Saye Khoo, Marco Siccardi, Geraint Davies, David Back and Dolores González‐Pacanowska. Their work appears in journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Clinical Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact